Daniel Grosslight
Stock Analyst at Citi
(3.12)
# 2,607
Out of 4,399 analysts
348
Total ratings
47.8%
Success rate
2.4%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMRS GMR Solutions | Initiated Coverage: Buy | $17 | $13.18 | +28.98% | 1 | Jun 8, 2026 | |
| ALGN Align Technology | Maintained: Buy | $240 | $170.50 | +40.76% | 2 | May 28, 2026 | |
| PHR Phreesia | Reiterated: Hold | $10 → $12 | $9.14 | +31.29% | 24 | May 28, 2026 | |
| ZTS Zoetis | Maintained: Buy | $145 → $112 | $81.29 | +37.78% | 2 | May 18, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $5.5 | $4.47 | +23.04% | 11 | May 15, 2026 | |
| AGL agilon health | Maintained: Hold | $19 → $80 | $101.70 | -21.34% | 9 | May 15, 2026 | |
| MCK McKesson | Rated: Buy | $860 → $945 | $790.44 | +19.55% | 15 | May 14, 2026 | |
| PAHC Phibro Animal Health | Rated: Hold | $62 → $44 | $31.18 | +41.12% | 2 | May 14, 2026 | |
| CTEV Claritev | Rated: Buy | $21 → $40 | $29.74 | +34.50% | 22 | May 14, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 → $4 | $2.56 | +56.25% | 28 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $22.90 | +39.74% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3.25 → $5 | $2.74 | +82.48% | 24 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $28 | $27.78 | +0.79% | 48 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 | $281.24 | +26.23% | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $31 | $22.87 | +35.55% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $11 | $10.04 | +4.58% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $7 | $7.03 | -0.43% | 38 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 → $30 | $18.80 | +59.57% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $244 → $245 | $216.30 | +13.27% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $100 | $78.85 | +26.82% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $650 | $556.94 | +16.71% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $24.06 | +20.53% | 1 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.25 → $2.75 | $1.60 | +72.41% | 18 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.16 | n/a | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 → $1.75 | $0.8646 | n/a | 10 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $19 → $8 | $9.59 | n/a | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $1.64 | n/a | 14 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $11 | $0.0001 | n/a | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $5.21 | n/a | 8 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.15 → $0.45 | $0.000001 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $9.93 | n/a | 1 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $25.89 | n/a | 1 | Nov 19, 2019 |
GMR Solutions
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $13.18
Upside: +28.98%
Align Technology
May 28, 2026
Maintained: Buy
Price Target: $240
Current: $170.50
Upside: +40.76%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $10 → $12
Current: $9.14
Upside: +31.29%
Zoetis
May 18, 2026
Maintained: Buy
Price Target: $145 → $112
Current: $81.29
Upside: +37.78%
Evolent Health
May 15, 2026
Maintained: Buy
Price Target: $4 → $5.5
Current: $4.47
Upside: +23.04%
agilon health
May 15, 2026
Maintained: Hold
Price Target: $19 → $80
Current: $101.70
Upside: -21.34%
McKesson
May 14, 2026
Rated: Buy
Price Target: $860 → $945
Current: $790.44
Upside: +19.55%
Phibro Animal Health
May 14, 2026
Rated: Hold
Price Target: $62 → $44
Current: $31.18
Upside: +41.12%
Claritev
May 14, 2026
Rated: Buy
Price Target: $21 → $40
Current: $29.74
Upside: +34.50%
GoodRx Holdings
May 14, 2026
Maintained: Buy
Price Target: $3.5 → $4
Current: $2.56
Upside: +56.25%
May 13, 2026
Maintained: Buy
Price Target: $32
Current: $22.90
Upside: +39.74%
May 12, 2026
Rated: Buy
Price Target: $3.25 → $5
Current: $2.74
Upside: +82.48%
May 12, 2026
Rated: Hold
Price Target: $24 → $28
Current: $27.78
Upside: +0.79%
May 7, 2026
Maintained: Buy
Price Target: $355
Current: $281.24
Upside: +26.23%
May 7, 2026
Maintained: Buy
Price Target: $30 → $31
Current: $22.87
Upside: +35.55%
May 6, 2026
Maintained: Sell
Price Target: $10 → $11
Current: $10.04
Upside: +4.58%
May 5, 2026
Rated: Hold
Price Target: $6 → $7
Current: $7.03
Upside: -0.43%
May 5, 2026
Rated: Buy
Price Target: $35 → $30
Current: $18.80
Upside: +59.57%
May 1, 2026
Rated: Buy
Price Target: $244 → $245
Current: $216.30
Upside: +13.27%
Apr 16, 2026
Initiated Coverage: Buy
Price Target: $100
Current: $78.85
Upside: +26.82%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $650
Current: $556.94
Upside: +16.71%
Apr 16, 2026
Initiated Coverage: Hold
Price Target: $29
Current: $24.06
Upside: +20.53%
Jan 9, 2026
Maintained: Hold
Price Target: $3.25 → $2.75
Current: $1.60
Upside: +72.41%
May 29, 2024
Maintained: Buy
Price Target: n/a
Current: $23.16
Upside: n/a
Sep 14, 2023
Maintained: Hold
Price Target: $1.25 → $1.75
Current: $0.8646
Upside: n/a
Aug 4, 2023
Downgraded: Sell
Price Target: $19 → $8
Current: $9.59
Upside: n/a
May 18, 2023
Maintained: Hold
Price Target: $7 → $9
Current: $1.64
Upside: n/a
Mar 9, 2023
Maintained: Hold
Price Target: $15 → $11
Current: $0.0001
Upside: n/a
Mar 1, 2023
Maintained: Hold
Price Target: $1
Current: $5.21
Upside: n/a
Nov 15, 2022
Maintained: Hold
Price Target: $1.15 → $0.45
Current: $0.000001
Upside: n/a
Dec 11, 2019
Initiated Coverage: Buy
Price Target: $13
Current: $9.93
Upside: n/a
Nov 19, 2019
Initiated Coverage: Buy
Price Target: $28
Current: $25.89
Upside: n/a